Riehl melanosis - I-Riehl Melanosishttps://en.wikipedia.org/wiki/Riehl_melanosis
Riehl Melanosis (Riehl melanosis) iwuhlobo lwe-contact dermatitis oluqala ngokuluma, i-erythema, kanye ne-pigmentation ezandayo kancane kancane, okuthi ngemva kokufinyelela izinga elithile, imile. Ukuchayeka elangeni ngemva kokusetshenziswa kwamakha athile noma ama-cream kungase kubangele lesi sifo.

☆ AI Dermatology — Free Service
Emiphumeleni ka-2022 ye-Stiftung Warentest evela eJalimane, ukwaneliseka kwabathengi nge-ModelDerm bekungaphansi kancane kunokuxhumana okukhokhelwayo kwe-telemedicine.
      References Riehl Melanosis 32491369 
      NIH
      Riehl melanosis ivamise ukwaziwa ngokuthi i-pigmented contact dermatitis. Kuyisimo sesikhumba esibangelwa ukungezwani komzimba nezinto ezithile, ngokuvamile ezibangelwa amakha nezinye izinto ezitholakala emikhiqizweni yezimonyo. Naphezu kokuthi kuhlukaniswa njengohlobo lwe-dermatitis, i-Riehl melanosis ibonisa izinguquko zombala esikhumbeni, ezinezimpawu ezincane kuphela zokucasuka. Ivame kakhulu kubantu abanesikhumba esimnyama. Ucwaningo lwakamuva luhlola ukusebenza kahle kokwelashwa nge-laser ye‑mid‑fluence Q‑switched Nd:YAG 1064‑nm ekubhekaneni nokujula kombala okuhlobene ne‑Riehl melanosis. Olunye ucwaningo luhlanganise izindlela ezihlukene zokwelapha, okuhlanganisa i‑low‑fluence 1064‑nm Q‑switched Nd:YAG laser, i‑hydroquinone cream, ne‑oral tranexamic acid, okwaholela ekuthuthukeni okubonakalayo ezigulini eziningi.
      Riehl melanosis (RM), commonly called pigmented contact dermatitis, is considered an acquired form of allergic contact dermatitis, typically to fragrance and other ingredients of cosmetic products. Although it is considered as a dermatitis, it presents clinically with hyperpigmentation over the face and shows pigment incontinence with minimal eczematous changes on histology. The condition is more commonly seen in dark-skinned people, causing an important psychosocial impact. A recent study showing the higher effectiveness of mid-fluence QSNY 1064-nm laser in targetting the deep pigmentation of RM has also been conducted. Another study used a combination of therapies to include low-fluence, 1064-nm, Q-switched Nd: YAG laser, hydroquinone cream, and oral tranexamic acid, with the majority of patients experiencing significant improvement.
       Research Advances in the Treatment of Riehl’s Melanosis 37168093 
      NIH
      I‑Riehl’s melanosis wuhlobo lwesimo sesikhumba esibangelwa ukuthintana nezinto ezithile ezingahambisani nokudla kanye nokuchayeka elangeni. Kuholela ekushintsheni kwesikhumba ngokushesha, sithuthukisa umbala ompunga, okungathinta kakhulu iziguli ngokwengqondo nangokomzimba. Nakuba imbangela yangempela ye‑Riehl’s melanosis ingaziwa, ucwaningo olukhona lubonisa isixhumanisi esinamandla sokuchayeka kwama‑allergen. Ukuze kutholakale ukwelashwa, kokubili imithi yendabuko kanye nokwelashwa nge‑laser kuye kwazanywa, ngokuvamile kuhambisana nokusetshenziswa kwama‑bleaching agents afakwa esikhumbeni. Ukwelashwa nge‑laser, ikakhulukazi kusetshenziswa i‑laser ye‑Q‑switched Nd:YAG, kubonise imiphumela ethembisayo yokwelapha i‑Riehl’s melanosis. Ukuhlanganisa izindlela ezahlukene zokwelapha kuholele emiphumeleni emihle.
      Riehl's melanosis (RM) is a contact photodermatitis, with fast progressive gray-brown skin pigmentation as the main manifestation, which can seriously affect the psychology and physiology of patients. Currently, although the etiological factors of Riehl's melanosis is still be unknown, the existing literature proves clearly the cause of it is related to the contacting with suspected allergens. For decades, there has been no standard method for the treatment of RM, but with both conventional drug therapy and laser therapy having been attempted. Topical application of bleaching agents is mainly used as an auxiliary treatment modality. The laser treatment modality remains a hot spot, among which Q-switched Nd:YAG laser is well received for RM. Positive outcomes have been achieved by the combined treatment modalities attempted in recent years also achieve positive outcomes.